This bulletin enumerates Medicare Part B drugs subject to the plan's step therapy program. Step therapy requires that a member try an initial agent (typically a different or less expensive drug) before a subsequent agent will be covered. The list includes biologics, oncology agents, injectables, immune globulins, and other specialty therapies. Exceptions to step therapy may be requested as described in the member's Evidence of Coverage.